National Comprehensive Cancer Network

About NCCN

NCCN Participates in the WHO Meeting

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

In April 2015, National Comprehensive Cancer Network® (NCCN®) leadership traveled to Geneva, Switzerland to participate in the World Health Organization (WHO) meeting: Consultation to Define Priority Medical Devices for Cancer Management Targeting Low and Middle Income Settings.

The objective of the WHO meeting was to present the methodology to select clinical interventions and medical devices from evidence-based clinical guidelines in breast, cervical, colorectal, lung, prostate cancers, and leukemia, as well as the common medical devices used for various types of cancers. In addition to the presentations, the WHO meeting served as a forum for discussion and input of world-renowned specialists in order to an action plan for future meetings.    

Benjamin O. Anderson, MD, Seattle Cancer Alliance, the chair of the NCCN International Program Committee, and Joan S. McClure, MS, Senior Vice President of Clinical Information and Publications, NCCN, discussed the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the delivery of high-quality oncology care, and the NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™) with the ultimate goal  of having the NCCN Framework™ adopted as the standard for global cancer care in order to provide the best possible outcomes given specific resource constraints.

“The panel members of the WHO had an encouragingly positive reaction to the presentations of the NCCN Framework,” said Ms. McClure.

The NCCN Framework™ outlines a rational approach for building cancer management systems to provide the highest achievable level of care for stage-specific cancers by applying available or attainable tests and treatments. In addition, the NCCN Framework™ can be used to define strategic pathways for growth by illustrating how new resources or tools introduced in a stepwise fashion can optimally improve on current best practice models and cancer outcomes.

The NCCN Framework™ for Cervical Cancer and the preliminary versions of Breast Cancer and Hepatobiliary Carcinoma (including Gall Bladder Cancer).are currently available on NCCN Framework™ for Gastric and Prostate Cancers will be published later this year.

 More information about NCCN Framework™ is available at

For more information about NCCN international initiatives, please visit